Generation of pECFP-C3-USP1 constructs highlights their roles in USP1 function and Bcr-Abl interactions in CML.
Aim. The aim of this study is to generate recombinant constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, essential for investigating the domain organization of the USP1 protein, determining their role in USP1 function, and analyzing their interaction with the oncoprotein Bcr-Abl. Methods. Standard molecular cloning techniques were employed, including polymerase chain reaction (PCR), ligation, restriction enzyme digestion, as well as DNA extraction and purification methods. Results. The genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, encoding key domains of the USP1 protein, were successfully designed and obtained. Conclusions. The generated genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2 will be utilized to study the role of these domains in USP1 function, its subcellular localization, and the formation of the Bcr-Abl/USP1 protein complex. These findings will contribute to a better understanding of the role of USP1 in cellular processes and facilitate the development of novel therapeutic approaches for the treatment of chronic myeloid leukemia (CML).
No takes yet. Share an insight, caveat, or question.
Matvieienko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: